Market revenue in 2022 | USD 52.7 million |
Market revenue in 2030 | USD 96.2 million |
Growth rate | 7.8% (CAGR from 2022 to 2030) |
Largest segment | Blood culture media |
Fastest growing segment | Assay Kits & Reagents |
Historical data covered | 2018 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Blood Culture Media, Assay Kits & Reagents, Software |
Key market players worldwide | BD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress |
Blood culture media was the largest segment with a revenue share of 38.9% in 2022. Horizon Databook has segmented the Latin America sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.
Sepsis represents a significant public health challenge in Latin America, characterized by a high incidence rate and substantial associated mortality. Early and accurate diagnosis of sepsis is crucial for initiating timely and appropriate treatment, which can prevent patient deterioration & enhance overall outcome. There is a growing focus on improving sepsis diagnosis within the region, driven by efforts to develop and implement innovative diagnostic tools.
In Latin America, where several countries face economic constraints, there is a pressing need for cost-effective diagnostic & treatment solutions. The region's diverse economic landscape includes low-income countries requiring affordable healthcare interventions and more developed nations with better access to advanced medical technologies.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account